Literature DB >> 29545343

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect.

Enrico Maffini1, Larry D Anderson2, Brenda M Sandmaier1,3, Damian J Green1,3, Barry E Storer1,4, Dietger Niederwieser5, Richard T Maziarz6, David G Maloney1,3, Rainer Storb7,3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29545343      PMCID： PMC6058792          DOI： 10.3324/haematol.2017.184176

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

Authors:  Athanasios Anagnostopoulos; Parameswaran N Hari; Waleska S Pérez; Karen Ballen; Asad Bashey; Christopher N Bredeson; César O Freytes; Robert Peter Gale; Morie A Gertz; John Gibson; Hartmut Goldschmidt; Hillard M Lazarus; Philip L McCarthy; Donna E Reece; David H Vesole; Sergio A Giralt
Journal:  Biol Blood Marrow Transplant       Date:  2006-08       Impact factor: 5.742

Review 2.  Long-term complications of lymphoma and its treatment.

Authors:  Andrea K Ng; Ann LaCasce; Lois B Travis
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

3.  Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.

Authors:  Robert F Cornell; Veronika Bachanova; Anita D'Souza; Kwang Woo-Ahn; Michael Martens; Jiaxing Huang; A Samer Al-Homsi; Saurabh Chhabra; Edward Copelan; Miguel-Angel Diaz; Cesar O Freytes; Robert Peter Gale; Siddhartha Ganguly; Mehdi Hamadani; Gerhard Hildebrandt; Rammurti T Kamble; Mohamed Kharfan-Dabaja; Tamila Kindwall-Keller; Hillard M Lazarus; David I Marks; Taiga Nishihori; Richard F Olsson; Ayman Saad; Saad Usmani; David H Vesole; Jean Yared; Tomer Mark; Yago Nieto; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-24       Impact factor: 5.742

4.  Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Charalampia Kyriakou; Carmen Canals; Jan J Cornelissen; Gerard Socié; Roel Willemze; Norbert Ifrah; Hildegard T Greinix; Didier Blaise; Eric Deconinck; Augustin Ferrant; Anton Schattenberg; Jean-Luc Harousseau; Anna Sureda; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2010-10-18       Impact factor: 44.544

5.  Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Authors:  Alice Garnier; Marie Robin; Fabrice Larosa; Jean-Louis Golmard; Steven Le Gouill; Valérie Coiteux; Reza Tabrizi; Claude-Eric Bulabois; Victoria Cacheux; Mathieu Kuentz; Brigitte Dreyfus; Peter Dreger; Bernard Rio; Marie-Pierre Moles-Moreau; Karin Bilger; Jacques-Olivier Bay; Véronique Leblond; Didier Blaise; Olivier Tournilhac; Nathalie Dhédin
Journal:  Haematologica       Date:  2010-01-15       Impact factor: 9.941

6.  Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.

Authors:  Rainer Storb; Boglarka Gyurkocza; Barry E Storer; Mohamed L Sorror; Karl Blume; Dietger Niederwieser; Thomas R Chauncey; Michael A Pulsipher; Finn B Petersen; Firoozeh Sahebi; Edward D Agura; Parameswaran Hari; Benedetto Bruno; Peter A McSweeney; Michael B Maris; Richard T Maziarz; Amelia A Langston; Wolfgang Bethge; Lars Vindeløv; Georg-Nikolaus Franke; Ginna G Laport; Andrew M Yeager; Kai Hübel; H Joachim Deeg; George E Georges; Mary E D Flowers; Paul J Martin; Marco Mielcarek; Ann E Woolfrey; David G Maloney; Brenda M Sandmaier
Journal:  J Clin Oncol       Date:  2013-03-11       Impact factor: 44.544

7.  Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:  Frédéric Baron; Jennifer E Baker; Rainer Storb; Theodore A Gooley; Brenda M Sandmaier; Michael B Maris; David G Maloney; Shelly Heimfeld; Dmitrij Oparin; Eustacia Zellmer; Jerald P Radich; F Carl Grumet; Karl G Blume; Thomas R Chauncey; Marie-Térèse Little
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

8.  The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study.

Authors:  Maria H Gilleece; Rachel Pearce; David C Linch; Marie Wilson; Keiren Towlson; Stephen Mackinnon; Michael Potter; Majid Kazmi; John G Gribben; David I Marks
Journal:  Hematology       Date:  2008-04       Impact factor: 2.269

9.  DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.

Authors:  C Yu; R Storb; B Mathey; H J Deeg; F G Schuening; T C Graham; K Seidel; R Burnett; J L Wagner; H Shulman; B M Sandmaier
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

10.  DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.

Authors:  R Storb; R F Raff; F R Appelbaum; H J Deeg; T C Graham; F G Schuening; H Shulman; C Yu; E Bryant; R Burnett
Journal:  Blood       Date:  1994-11-15       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.